2 results
Approved WMOCompleted
This study will evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of MTAU9937A in patients with prodromal or mild Alzheimer*s disease (AD), ages 50*80, who are amyloid positive by cerebrospinal fluid (CSF) or amyloid positron…
Approved WMOCompleted
The purposes of this feasibility study are: • to evaluate the correlation between COPD-related dyspnea and the EMG of respiratory muscles when simulating daily activities, to assess the dyspnea symptom in a more objective (measurable) way; • to…